Dr. Luca Rosignoli is a Austin, Texas based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Luca Rosignoli is V0140 for Ophthalmology in Texas. Dr. Luca Rosignoli is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Luca Rosignoli speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
801 W 38th St Ste 200, Austin, Texas, 78705-1169
Phone:
512-451-0103
Fax:
512-451-2741
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1043773187
NPI Enumeration Date:
06 Apr, 2019
NPI Last Update On:
07 May, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Luca Rosignoli are as mentioned below.
License Number
Specialization
State
Status
V0140
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1512 W 35th St Ste 200, Austin, Texas
Zip:
78703-1437
Phone Number:
512-451-0103
Fax Number:
512-454-2741
Patients can reach Dr. Luca Rosignoli at 801 W 38th St Ste 200, Austin, Texas or can call to book an appointment on 512-451-0103. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.